Gene Expression Profile Analysis of T1 and T2 Breast Cancer Reveals Different Activation Pathways

Table 1

Summary of patient characteristics.

Sample	Stage	Size/cm	Grade	Node	ER	PgR	Recurrence/metastasis	Deceased
24	T1	0.8	2	1	Positive	Positive
29	T1	0.8	2	0	Positive	Positive
51	T1	1.0	1	0	Positive	Negative
55	T1	0.8	3	0	Positive	Positive
62	T2	2.5	3	2	Negative	Negative
69	T1	1.4	2	0	Positive	Positive
73	T1	1.8	2	0	Positive	Positive
78	T1	1.2	2	0	Positive	Positive
81	T2	2.3	2	1	Positive	Positive
83	T1	1.9	3	1	Positive	Positive
84	T1	1.0	2	0	Positive	Positive
94	T1	1.9	3	0	Positive	Negative	Yes	Yes
99	T2	4.0	3	0	Negative	Negative
101	T1	1.9	3	0	Positive	Positive		Yes
122	T2	3.4	3	1	Positive	Negative		Yes
124	T1	0.9	1	0	Positive	Positive
129	T1	0.8	2	0	Positive	Negative
130	T2	2.2	3	2	Positive	Positive	Yes	Yes
143	T2	2.8	2	0	Positive	Positive
147	T1	1.0	1	0	Positive	Positive
148	T1	0.9	2	0	Positive	Positive
149	T1	1.0	1	0	Positive	Positive
152	T1	1.5	2	1	Positive	Positive
170	T2	4.0	2	1	Negative	Negative
172	T1	1.9	2	1	Negative	Negative		Yes
175	T2	2.5	3	0	Negative	Negative
176	T2	2.7	3	0	Positive	Positive
178	T1	1.2	2	1	Negative	Positive	Yes	Yes
179	T1	1.8	2	1	Positive	Positive
191	T1	1.4	1	0	Positive	Positive
200	T1	1.5	2	0	Negative	Positive
211	T1	1.7	2	2	Positive	Positive
213	T2	3.0	3	1	Negative	Negative
214	T1	1.2	2	0	Positive	Negative
218	T2	2.1	1-2	1	Positive	Negative
222	T2	2.1	2	0	Positive	Positive	New BC
227	T1	1.8	2	0	Negative	Positive
228	T2	3.0	3	0	Negative	Negative
231	T2	2.1	2	0	Positive	Negative
233	T2	3.0	3	0	Negative	Negative	New BC
237	T2	2.1	2	0	Positive	Positive
244	T1	0.6	2	0	Positive	Positive
270	T2	3.0	3	0	Positive	Negative	Yes
272	T2	2.3	2	1	Positive	Negative
280	T2	3.2	2	0	Negative	Positive
283	T1	1.3	2	1	Positive	Negative